Phase 1 Development of Radspherin

Time: 2:00 pm
day: Day 1 Track A


• Radspherin®, is a new alpha-emitting radioactive microsphere designed for treatment of metastatic cancers in body cavities
• Radspherin® has in animal models been shown to cause a reduction in tumour cell growth and a significant increased survival